Searchable abstracts of presentations at key conferences in endocrinology

ea0038p3 | Bone | SFEBES2015

Reduction in daily hydrocortisone dose in adrenal insufficiency improves significantly bone mineral density – results from a 2-years prospective trial

Schulz Julia , Koetz Kathrin , Ventz Manfred , Diederich Sven , Quinkler Marcus

Introduction: Patients with primary adrenal insufficiency (PAI) and patients with congenital adrenal hyperplasia (CAH) receive life-long glucocorticoid (GC) replacement therapy. Today daily GC doses are still higher than the reported adrenal cortisol production rate, and are not able to reproduce the physiological secretion pattern. This might result in long-term morbidities such as osteoporosis. Until now no prospective trial was performed investigating the long-term effect o...

ea0038p407 | Steroids | SFEBES2015

Conventional vs modified release hydrocortisone in mitotane treated patients with adrenocortical cancer

Weigel Marianne , Hahner Stefanie , Beier Daniela , Zopf Kathrin , Quinkler Marcus

Background: Mitotane is a strong inducer of hepatic CYP3A4 activity (cortisol metabolism) and increases cortisol-binding globulin (CBG). High hydrocortisone dosages are necessary in patients with adrenocortical cancer (ACC) on mitotane treatment. The newly modified release hydrocortisone has not been used in mitotane-treated ACC patients yet.Aim: To compare cortisol (serum and saliva), calculated free serum cortisol and ACTH levels in ACC patients on mit...

ea0035p44 | Adrenal cortex | ECE2014

Bone mineral density does not decrease in patients with adrenal insufficiency on a low daily glucocorticoid dose over a 2 year period

Schulz Julia , Koetz Kathrin , Ventz Manfred , Diederich Sven , Quinkler Marcus

Introduction: Patients with primary adrenal insufficiency (PAI) and patients with congenital adrenal hyperplasia (CAH) receive glucocorticoid replacement therapy, which might cause osteoporosis.Objective: i) Is bone mineral density (BMD) depending on the height of the daily glucocorticoid dose? ii) Is BMD decreasing over a 2-year period of glucocorticoid replacement therapy?Methods: Prospective, longitudinal study including 56 pati...

ea0028p46 | Clinical practice/governance and case reports | SFEBES2012

Improvement of health-related quality of life in adult women with 21-hydroxylase deficiency over a 7 years period

Quinkler Marcus , Ventz Manfred , Hinz Andreas , Bleicken Benjamin

Introduction: Health related quality of life (HRQoL) is impaired in adult patients with 21-hydroxylase deficiency (21-OHD). Up to now, only cross-sectional and no longitudinal studies are available, and it is not known if HRQoL can be improved in adult 21-OHD patients. Objective: To investigate HRQoL in adult female 21-OHD patients over a longer time span.Methods: Longitudinal, single centre, follow-up study over seven years with three visits including 1...

ea0028p322 | Steroids | SFEBES2012

Modified-release prednisolone increases quality of life compared to standard prednisolone in patients with adrenal insufficiency

Quinkler Marcus , Ventz Manfred , Hinz Andreas , Langenheim Jorinde

Context: Patients with adrenal insufficiency (AI) receive glucocorticoid replacement therapy, which tries to imitate physiological adrenal secretion. However, the first glucocorticoid dose is usually given after waking in the morning resulting in a 3–5 h delay compared to physiological secretion. Impaired quality of life (QoL) might be, in part, due to this delayed dose scheme. Therefore, modified-release glucocorticoid preparations might have therapeutical advantages.</p...

ea0025p9 | Bone | SFEBES2011

Bone mineral density in patients with primary adrenal insufficiency compared to patients with congenital adrenal hyperplasia

Koetz Kathrin , Ventz Manfred , Diederich Sven , Quinkler Marcus

Introduction: Patients with primary adrenal insufficiency (Addison’s disease) and patients with congenital adrenal hyperplasia (CAH) still tend to receive more glucococorticoids than the normal endogenous production in healthy subjects. CAH patients start glucocorticoid treatment usually with diagnosis in their early childhood, whereas Addison’s patients have a later onset of their disease and start of their treatment.Objective: To compare pati...

ea0021p14 | Bone | SFEBES2009

Mutational analysis of the PHEX gene in three patients with X-linked hypophosphatemic rickets: discovery of a novel point mutation

Kienitz Tina , Ventz Manfred , Kaminsky Elke , Quinkler Marcus

Introduction: X-linked hypophosphatemic rickets is the most common form of familial hypophosphatemic rickets. It is caused by a defect in renal phosphate transport leading to phosphate wasting and hypophosphatemia. Furthermore 1,25-dihydroxyvitamin D concentrations are inappropriately normal in regard to hypophosphatemia. Clinical manifestation of the disease are skeletal deformities, short stature, osteomalacia, dental abscesses, bone pain, and loss of hearing. PHEX is locate...

ea0016oc6.6 | Metabolism and cardiovascular | ECE2008

Androgens increase blood pressure in orchiectomized male Wistar rats similar to high salt diet

Hofmann Peter , Michaelis Marten , Gotz Franziska , Quinkler Marcus

Introduction: With the onset of puberty blood pressure increases more in men than in women while boys and girls do not show any gender differences in blood pressure. Androgens are known to play an important role in renal tubular epithelial cell growth, hypertrophy and erythropoetin production and may be important determinants of sex-specific differences in blood pressure. However, the exact mechanisms are not clear yet.Methods: Male Wistar rats aged 8&#1...

ea0016p668 | Steroid receptors | ECE2008

Testosterone increases kidney weight in orchiectomized male Wistar rats but not dihydrotestosterone

Michaelis Marten , Hofmann Peter , Rohde Wolfgang , Gotz Franziska , Quinkler Marcus

Introduction: Androgens are known to play an important role in renal tubular epithelial cell growth, hypertrophy and erythropoetin production, however the exact mechanisms are not clear yet. 5alpha-dihydrotestosterone is synthesized primarily in gonads and skin, and is the most used androgen in studies. However, little is known about testosterone effects in non-gonadal tissues.Methods: Male Wistar rats aged 8–10 weeks were orchiectomized and put on ...

ea0015p143 | Diabetes, metabolism and cardiovascular | SFEBES2008

Androgens increase blood pressure in orchiectomized male Wistar rats similar to high salt diet

Hofmann Peter , Michaelis Marten , Goetz Franziska , Quinkler Marcus

Introduction: With the onset of puberty blood pressure increases more in men than in women while boys and girls do not show any gender differences in blood pressure. Androgens are known to play an important role in renal tubular epithelial cell growth, hypertrophy and erythropoetin production and may be important determinants of sex-specific differences in blood pressure. However the exact mechanisms are not clear yet.Methods: Male Wistar rats aged 8&#15...